Red Dye 3 vs Monosodium Glutamate: which is worse?

What is Red Dye 3?

Red Dye 3 (erythrosine) is a synthetic cherry-pink fluorescent dye belonging to the xanthene class. It contains approximately 58% iodine by weight, distinguishing it from azo dyes. Its chemical formula is C20H6I4Na2O5. Approved since 1907, it is one of the oldest certified US food colorants and was notably the first synthetic food dye formally revoked by the FDA in decades.

What is Monosodium Glutamate?

Monosodium glutamate (MSG) is the sodium salt of glutamic acid, a naturally occurring non-essential amino acid found in many proteins. It is used as a flavor enhancer to intensify umami (savory) taste. MSG was first isolated from seaweed in 1908 by Japanese chemist Kikunae Ikeda and has been used commercially since then.

Documented risks

Red Dye 3: The FDA revoked Red Dye 3 authorization in January 2025, marking the first synthetic food dye ban by the FDA since Red Dye 2 in 1976. The revocation was triggered by the Delaney Clause, which mandates revocation of any food additive found to cause cancer in animals regardless of dose. The carcinogenicity data stems from studies showing that high doses of erythrosine caused thyroid follicular cell tumors in male rats. The mechanism is indirect: erythrosine suppresses thyroid-stimulating hormone (TSH) feedback by elevating thyroxine (T4) levels, causing chronic TSH suppression that promotes thyroid cell proliferation and ultimately tumor formation. This is a rat-specific mechanism related to their thyroxine-binding protein system, which differs from human biology. EFSA's 2011 comprehensive safety assessment concluded erythrosine was unlikely to be genotoxic at typical food use levels and set an ADI of 0.1 mg/kg body weight — one of the lowest for any food color. EFSA restricted EU use to cocktail cherries only (max 200 mg/kg). The high iodine content (58% by weight) raises concerns for thyroid-sensitive individuals. Excessive erythrosine intake could theoretically contribute to iodine overload and thyroid disruption, particularly in individuals with hyperthyroidism or Hashimoto's disease. The FDA had been aware of the rat thyroid tumor data since 1990 but delayed action for 35 years. Advocacy groups including CSPI petitioned for a ban since 1983. The January 2025 revocation finally addressed this long-standing regulatory gap.

Monosodium Glutamate: MSG safety has been one of the most extensively debated food additive questions in the past 50 years. The 'Chinese Restaurant Syndrome' — a cluster of symptoms (headache, flushing, sweating, chest tightness) reported after eating Chinese food — was attributed to MSG in a 1968 letter in the New England Journal of Medicine. This set off decades of controversy. Multiple rigorous double-blind, placebo-controlled trials have failed to consistently demonstrate that MSG at doses present in food causes these symptoms when participants do not know whether they received MSG or a placebo. A comprehensive 1993 review by the FDA-commissioned Federation of American Societies for Experimental Biology (FASEB) found that while some sensitive individuals may experience symptoms at high doses (>3g of pure MSG on an empty stomach), the doses in typical food servings do not consistently produce symptoms in double-blind conditions. The FDA classifies MSG as GRAS (generally recognized as safe). EFSA's 2017 re-evaluation set an ADI of 30 mg/kg body weight per day, acknowledging that very high doses could affect neurological function but concluding typical dietary exposure is safe. Critics including Dr. Russell Blaylock and advocacy groups have argued that MSG is an 'excitotoxin' — a compound that overstimulates glutamate receptors in the brain and could cause neuronal damage. While glutamate is indeed a neurotransmitter and high-dose glutamate can cause neurotoxicity in animal models, the blood-brain barrier and normal metabolic regulation are generally considered sufficient to prevent dietary MSG from affecting brain glutamate levels. A 2018 EFSA re-evaluation noted that combined exposure to glutamates from all sources (including naturally occurring glutamate in protein-rich foods and other added glutamates E621-E625) could approach the new lower ADI in high consumers — a concern particularly for children with high processed food intake.